DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin

Information source: Hadassah Medical Organization
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Upper Tract Ureterolithiasis

Intervention: Tamsulosin (Drug)

Phase: Phase 2

Status: Not yet recruiting

Sponsored by: Hadassah Medical Organization

Official(s) and/or principal investigator(s):
Mordechai Duvdevani, MD, Principal Investigator, Affiliation: Hadassah Medical Organization

Overall contact:
Mordechai Duvdevani, MD, Phone: 0508946816, Email: moti_duv@yahoo.com

Summary

The purpose of this study is to see whether patients undergoing ESWL, for upper tract urinary stones between 1. 5-2. 0cm, may be treated by expulsion therapy(Tamsulosin) instead of inserting ureteral stents .

Clinical Details

Official title: Phase II Study Comparing Two Groups of Patients Undergoing ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin

Study design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment

Primary outcome:

stone status at 3 month .

stone free

Eligibility

Minimum age: 18 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients above 18 yrs of age.

- Single urolithiasis up to 2 cm.

- Kidney/ureters that haven't undergone previous ESWL or stent insertion.

- Normal renal function (creatinine below 100mmo1/1).

- Sterile urine culture.

- Normal CBC, blood electrolytes and coagulation studies.

- Radioopaque stones.

Exclusion Criteria:

- More than one stone per kidney unit.

- Patients receiving steroids, NSAIDS, calcium channel blockers or alpha blockers on a

regular basis.

- Anatomical anomalies or uromechanical obstruction.

- Single kidney.

- Cystinuria.

- Soldiers or pregnant women.

- Patients under 18 year

Locations and Contacts

Mordechai Duvdevani, MD, Phone: 0508946816, Email: moti_duv@yahoo.com

Hadassah Medical Organization, Jerusalem 91120, Israel
Additional Information


Last updated: May 24, 2007

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009